羚锐制药：核24H1净利增长30%，扎实的品牌及营销工作或将助力业绩创新高
Lingrui Pharma(SH:600285) Xinda Securities·2024-08-13 08:10| --- | --- | |----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...